Navigation Links
World Health Organization releases latest Dengue Bulletin
Date:6/17/2011

n a facility-level observational study of dengue patients. The authors found that the economic cost per non-fatal case in Khon Kaen Provincial Hospital in 2005 averaged US$ 573. Some previous economic studies have examined only household out-of-pocket payments for treatment. This study measured total resource use from all sources, including government, households and employers. On average, inpatient care cost US$ 418 per case, almost all is paid for by the government. Ambulatory care and direct non-medical care (mostly transportation) averaged US$ 49 and US$ 60 per case, respectively. Further, indirect costs (the value of time lost) averaged US$ 45 per case, mostly incurred by households. Thus, all payers incur substantial costs for a dengue case.

Finally, the paper also estimated the cost of vector control, an important dimension that is empirically derived in very few studies. Overall, per capita costs of dengue in Thailand in 2005 were US$ 3.55, of which 28% was due to vector control and 72% due to dengue illness.

The tenth study, Clinical characterization, diagnosis and socioeconomic impact of hospitalized dengue in Cambodia, by Jose A. Suaya and co-authors, uses the same data collection instruments and methods as the ninth paper (from Thailand). When measured in US dollars, the resource cost of a hospitalized dengue case in Cambodia (US$ 116) was substantially less than that in Thailand. Yet the economic hardship associated with a dengue hospitalization in Cambodia was extraordinarily high, with the majority (88%) of households having these cases reporting a substantial adverse economic impact. For example, to pay for treatment, 39% of the households needed to borrow money beyond family or friends, and 53% needed to sell household property. These adverse effects are the combined results of considerably lower per capita income and the requirement in Cambodia that patients pay out-of-pocket for the majority of hospital costs, even in a governm
'/>"/>

Contact: Susan Chaityn Lebovits
lebovits@brandeis.edu
781-736-4027
Brandeis University
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. NASA satellite gallery shows Chilean volcano plume moving around the world
2. First-of-its-kind fluorescence map offers a new view of the worlds land plants
3. ACSM: Weight loss success in a 3-D virtual world
4. 1 world, 1 sound
5. Void in leadership on world water crisis cited by 20 former heads of government
6. Tiny bubbles signal severe impacts to coral reefs worldwide
7. World-wide assessment determines differences in cultures
8. First analysis of invasive plant impacts worldwide
9. The Pantanal: A book on the ecology of the largest contiguous wetland in the world
10. The True Shrikes (Laniidae) of the World by E.N. Panov
11. Worm discovery could help 1 billion people worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting ... company and has launched a new marketing campaign to ... Organization (CLO).  The new campaign focuses on First ... protocol and shipments. The first headline in ... aligns Marken,s priorities with its client,s priorities. Marken recognizes ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... day of competition in London, a team of four ... emerged as the winners of this year,s Biotechnology Young ... Biotechnology Young Entrepreneurs Scheme (YES) competition are Ben Owens, ... University of Oxford. The team pitched their ...
... Stem cell scientists at King,s College London will today ... UK Stem Cell Bank (UKSCB) their first clinical grade ... from animal-derived products, known as ,xeno-free, stem cells. ... ,gold standard, lines for developing new stem cell-based therapies, ...
... Darrel Tremaine has been known to go to extremes for ... through a dark, muddy limestone cave in Northwest Florida to ... His goal? To compare ancient meteorological patterns with modern ones ... policymakers on how to build a sustainable water supply. ...
Cached Biology News:Winning early-career researchers excel in entrepreneurship 2Winning early-career researchers excel in entrepreneurship 3Stem cell research in the UK reaches significant milestone 2Stem cell research in the UK reaches significant milestone 3Stem cell research in the UK reaches significant milestone 4Researcher finds key to ancient weather patterns in Florida's caves 2Researcher finds key to ancient weather patterns in Florida's caves 3Researcher finds key to ancient weather patterns in Florida's caves 4
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited (ASX:BNO, ... DisrupTOR-1 trial of BNC105 in patients with metastatic renal ... Orlando, Florida . The data will be ... City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 as ...
(Date:2/27/2015)... South San Francisco, CA (PRWEB) February 27, 2015 ... it is joining forces on February 28 with patients ... globally to raise awareness for Rare Disease Day®. ... of rare diseases and calling attention to the special ... support community around them. , “Cytokinetics is proud to ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital IQ ... Stock Report coverage on MabVax Therapeutics Holdings Inc . ... a clinical stage biotechnology company focused on the development ... needs in the treatment of cancer. MabVax has discovered ... the protective immune responses generated by patients who have ...
(Date:2/26/2015)... TORONTO , Feb. 26, 2015 /PRNewswire/ - SQI ... SQIDF), a life sciences company that develops and commercializes ... reported its financial and operational results for the fiscal ... this press release are in Canadian dollars (CAD), unless ... Company continued to win new business from our existing ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Company Posts Fourth Quarter EPS of $0.37, Up 16% -, - For ... Up 41%; Total Revenues and Product ... Income Growth in Four Years, ... $1.72 -, SAN DIEGO, Feb. 13 Gen-Probe Incorporated,(Nasdaq: GPRO ...
... Inverness Medical,Innovations (Amex: IMA ) today announced ... was successfully completed on February 12,2008. BBI, located ... manufacture of non-invasive lateral flow tests and has ... reagents. The,final purchase price consisted of cash of ...
... 13 The following statement,is attributable to Kathy ... Control and Epidemiology (APIC):, "APIC is concerned ... as high as 70 percent according to recent ... strain, provide evidence that,the very nature of these ...
Cached Biology Technology:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 2Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 3Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 4Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 5Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 6Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 7Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 8Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 9Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 10Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 11Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 12Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 13Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 14Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 15Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 16APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs) 2